Table 2.
MINORS Score Itemb | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lead Author (Year) | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Overall |
Enea6 (2018) | 2 | 2 | 1 | 2 | 0 | 2 | 0 | 2 | 2 | 2 | 1 | 2 | 18 |
Fabricant7 (2014) | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 0 | — | — | — | — | 12 |
Marteau14 (2011) | 2 | 2 | 1 | 2 | 0 | 2 | 1 | 0 | — | — | — | — | 10 |
Mayer15 (2012) | 2 | 2 | 1 | 2 | 0 | 2 | 1 | 0 | — | — | — | — | 10 |
Otsuki17 (2013) | 2 | 2 | 1 | 2 | 0 | 2 | 2 | 0 | — | — | — | — | 11 |
Otsuki16 (2017) | 2 | 2 | 1 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 21 |
Otsuki18 (2018) | 2 | 2 | 1 | 2 | 0 | 2 | 2 | 0 | — | — | — | — | 11 |
Roessler21 (2019) | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 21 |
Rood22 (2020) | 2 | 2 | 1 | 2 | 0 | 1 | 2 | 0 | — | — | — | — | 10 |
Simmons23 (1992) | 2 | 2 | 1 | 2 | 0 | 2 | 2 | 0 | — | — | — | — | 11 |
Yang33 (2019) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | — | — | — | — | 15 |
aMINORS, Methodological Index for Non-Randomized Studies. The dashes indicate that the category of evaluation was not relevant to the article assessed.
bItem descriptions: 1, stated aim of the study; 2, inclusion of consecutive patients; 3, prospective collection of data; 4, endpoint appropriate to the study aim; 5, unbiased evaluation of endpoints; 6, follow-up period appropriate; 7, loss to follow-up not exceeding 5%; 8, a control group having the gold standard intervention; 9, contemporary groups; 10, baseline equivalence of groups; 11, prospective calculation of the sample size; and 12, statistical analyses adapted to the study design.